Search Results for: Morphine

July 4, 2020July 4, 2020

Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease.

Publication date: Jul 01, 2020 Continuous subcutaneous (s.c.) apomorphine infusion is an effective therapy for Parkinson’s disease (PD), but a limitation is the formation of troublesome s.c. nodules. Various chemically ... Read more

July 3, 2020July 3, 2020

Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)

Opioids News

Publication date: Jul 02, 2020 This randomized control trial will compare buprenorphine and morphine, two currently used medications for the treatment of neonatal opioid withdrawal syndrome (NOWS), in newborns to ... Read more

June 25, 2020June 25, 2020

The Efficacy of Morphine Versus Dexmedetomidine as an Adjunct to Caudal Anesthesia

Opioids News

Publication date: Jun 24, 2020 The aim of this study is to compare the duration of post-operative analgesia, sedation, and any side effects of caudal dexmedetomidine versus morphine in combination ... Read more

June 16, 2020June 16, 2020

Sunovion Announces Health Canada Approval of KYNMOBI™ (apomorphine hydrochloride) Soluble Film for the Treatment of Parkinson’s Disease OFF Episodes

Parkinson's Disease News

Publication date: Jun 16, 2020 Concepts Keywords Antony Parkinson’s disease Anxiety Carbidopa Apomorphine Apomorphine Biopharmaceutical Cynapsus Therapeutics Brain Neuroscience Canada Cell therapy Canadian Regenerative medicine Carbidopa Sunovion Caregiver Health Cell ... Read more

$Experience of morphine therapy for refractory dyspnea as palliative care in advanced heart failure patients.$

June 1, 2020June 1, 2020

Experience of morphine therapy for refractory dyspnea as palliative care in advanced heart failure patients.

Opioids Literature

Publication date: Jun 01, 2020 In the field of palliative care, morphine is known to be effective for alleviating dyspnea in cancer patients. However, little is known regarding the safety ... Read more

May 31, 2020May 31, 2020

Beneficial effects of physical activity on depressive and OCD-like behaviors in the male offspring of morphine-abstinent rats.

Major Depressive Disorder Literature

Publication date: May 27, 2020 The role of parental morphine exposure before gestation on mood disorder in the offspring was well described. Besides, physical activity can improve the symptoms of ... Read more

May 28, 2020May 28, 2020

Antagonism of peripheral opioid receptors by methylnaltrexone does not prevent morphine tolerance in rats.

Opioids Literature

Publication date: May 27, 2020 Opioids are effective analgesics in the management of severe pain. However, tolerance, leading to dose escalation and adverse effects are significant limiting factors in their ... Read more

May 15, 2020May 15, 2020

Intraosseous Morphine in Primary TKA

Opioids News

Publication date: May 14, 2020 The research team wants to investigate if an intraosseous injection (directly into the bone marrow) of morphine during primary total knee replacement helps with post-operative ... Read more

May 10, 2020May 10, 2020

Targeting morphine-responsive neurons: generation of a knock-in mouse line expressing Cre recombinase from the mu opioid receptor gene locus.

Opioids Literature

Publication date: May 07, 2020 The mu opioid receptor (MOR) modulates nociceptive pathways, reward processing, and mediates the strong analgesic and addictive properties of both medicinal as well as abused ... Read more

April 27, 2020April 27, 2020

Dopamine D or D receptor modulators prevent morphine tolerance and reduce opioid withdrawal symptoms.

Opioids Literature

Publication date: Apr 23, 2020 The long-term treatment of chronic pain by opioids is limited by tolerance and risk of addiction/dependence. Previously, we have shown that combination treatment of morphine ... Read more